460 related articles for article (PubMed ID: 25824297)
1. CXCR4 attenuates cardiomyocytes mitochondrial dysfunction to resist ischaemia-reperfusion injury.
Cai WF; Kang K; Huang W; Liang JL; Feng YL; Liu GS; Chang DH; Wen ZL; Paul C; Xu M; Millard RW; Wang Y
J Cell Mol Med; 2015 Aug; 19(8):1825-35. PubMed ID: 25824297
[TBL] [Abstract][Full Text] [Related]
2. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
3. Kaempferol protects cardiomyocytes against anoxia/reoxygenation injury via mitochondrial pathway mediated by SIRT1.
Guo Z; Liao Z; Huang L; Liu D; Yin D; He M
Eur J Pharmacol; 2015 Aug; 761():245-53. PubMed ID: 26086862
[TBL] [Abstract][Full Text] [Related]
4. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
[TBL] [Abstract][Full Text] [Related]
5. Elatoside C protects the heart from ischaemia/reperfusion injury through the modulation of oxidative stress and intracellular Ca²⁺ homeostasis.
Wang M; Sun GB; Zhang JY; Luo Y; Yu YL; Xu XD; Meng XB; Zhang MD; Lin WB; Sun XB
Int J Cardiol; 2015 Apr; 185():167-76. PubMed ID: 25796004
[TBL] [Abstract][Full Text] [Related]
6. Danhong injection protects cardiomyocytes against hypoxia/reoxygenation- and H2O2-induced injury by inhibiting mitochondrial permeability transition pore opening.
Duan ZZ; Li YH; Li YY; Fan GW; Chang YX; Yu B; Gao XM
J Ethnopharmacol; 2015 Dec; 175():617-25. PubMed ID: 26320687
[TBL] [Abstract][Full Text] [Related]
7. Synergistic protective effect of cyclosporin A and rotenone against hypoxia-reoxygenation in cardiomyocytes.
Teixeira G; Abrial M; Portier K; Chiari P; Couture-Lepetit E; Tourneur Y; Ovize M; Gharib A
J Mol Cell Cardiol; 2013 Mar; 56():55-62. PubMed ID: 23238221
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms involved in postconditioning protection of cardiomyocytes against acute reperfusion injury.
Shahzad T; Kasseckert SA; Iraqi W; Johnson V; Schulz R; Schlüter KD; Dörr O; Parahuleva M; Hamm C; Ladilov Y; Abdallah Y
J Mol Cell Cardiol; 2013 May; 58():209-16. PubMed ID: 23328483
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin gallate prevents mitochondrial impairment and cell apoptosis by regulating miR-30a/p53 axis.
Zhang C; Liao P; Liang R; Zheng X; Jian J
Phytomedicine; 2019 Aug; 61():152845. PubMed ID: 31029907
[TBL] [Abstract][Full Text] [Related]
10. Elatoside C protects against hypoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes through the reduction of endoplasmic reticulum stress partially depending on STAT3 activation.
Wang M; Meng XB; Yu YL; Sun GB; Xu XD; Zhang XP; Dong X; Ye JX; Xu HB; Sun YF; Sun XB
Apoptosis; 2014 Dec; 19(12):1727-35. PubMed ID: 25326083
[TBL] [Abstract][Full Text] [Related]
11. Picroside Ⅱ inhibits hypoxia/reoxygenation-induced cardiomyocyte apoptosis by ameliorating mitochondrial function through a mechanism involving a decrease in reactive oxygen species production.
Li JZ; Yu SY; Mo D; Tang XN; Shao QR
Int J Mol Med; 2015 Feb; 35(2):446-52. PubMed ID: 25421707
[TBL] [Abstract][Full Text] [Related]
12. Altered FoF1 ATP synthase and susceptibility to mitochondrial permeability transition pore during ischaemia and reperfusion in aging cardiomyocytes.
Fernandez-Sanz C; Ruiz-Meana M; Castellano J; Miro-Casas E; Nuñez E; Inserte J; Vázquez J; Garcia-Dorado D
Thromb Haemost; 2015 Mar; 113(3):441-51. PubMed ID: 25631625
[TBL] [Abstract][Full Text] [Related]
13. Moderate Hydrogen Peroxide Postconditioning Ameliorates Ischemia/Reperfusion Injury in Cardiomyocytes via STAT3-Induced Calcium, ROS, and ATP Homeostasis.
Wu L; Huang WQ; Yu CC; Li YF
Pharmacology; 2021; 106(5-6):275-285. PubMed ID: 33302272
[TBL] [Abstract][Full Text] [Related]
14. ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca(2+) overload and contractile dysfunction via the JAK2/STAT3 pathway.
Wu L; Tan JL; Wang ZH; Chen YX; Gao L; Liu JL; Shi YH; Endoh M; Yang HT
J Mol Cell Cardiol; 2015 Apr; 81():150-61. PubMed ID: 25731682
[TBL] [Abstract][Full Text] [Related]
15. JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury.
Yang Y; Duan W; Jin Z; Yi W; Yan J; Zhang S; Wang N; Liang Z; Li Y; Chen W; Yi D; Yu S
J Pineal Res; 2013 Oct; 55(3):275-86. PubMed ID: 23796350
[TBL] [Abstract][Full Text] [Related]
16. Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury.
Zhao Y; Guo R; Li L; Li S; Fan G; Zhao X; Wang Y
Biomed Pharmacother; 2020 Dec; 132():110897. PubMed ID: 33113431
[TBL] [Abstract][Full Text] [Related]
17. HDAC inhibition induces autophagy and mitochondrial biogenesis to maintain mitochondrial homeostasis during cardiac ischemia/reperfusion injury.
Yang J; He J; Ismail M; Tweeten S; Zeng F; Gao L; Ballinger S; Young M; Prabhu SD; Rowe GC; Zhang J; Zhou L; Xie M
J Mol Cell Cardiol; 2019 May; 130():36-48. PubMed ID: 30880250
[TBL] [Abstract][Full Text] [Related]
18. TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition.
Schaller S; Paradis S; Ngoh GA; Assaly R; Buisson B; Drouot C; Ostuni MA; Lacapere JJ; Bassissi F; Bordet T; Berdeaux A; Jones SP; Morin D; Pruss RM
J Pharmacol Exp Ther; 2010 Jun; 333(3):696-706. PubMed ID: 20215409
[TBL] [Abstract][Full Text] [Related]
19. Isoflurane protects cardiomyocytes and mitochondria by immediate and cytosol-independent action at reperfusion.
Pravdic D; Mio Y; Sedlic F; Pratt PF; Warltier DC; Bosnjak ZJ; Bienengraeber M
Br J Pharmacol; 2010 May; 160(2):220-32. PubMed ID: 20423337
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cell-volume regulation in cyclosporin A cardioprotection.
Diaz RJ; Fernandes K; Lytvyn Y; Hawrylyshyn K; Harvey K; Hossain T; Hinek A; Wilson GJ
Cardiovasc Res; 2013 Jun; 98(3):411-9. PubMed ID: 23483048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
